UBS Group AG - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Amneal Pharmaceuticals, Inc. (AMRX)

Filing Manager: UBS Group AG
Reporting Manager: UBS Group AG
Security: Amneal Pharmaceuticals, Inc. Class A Common Stock, par value $0.01 per share
Symbol: AMRX
Form type: SCHEDULE 13G/A
Date filed: 2/10/2025, 08:59 AM
Date of event: Dec 31, 2024
Previous filing: Oct 30, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
UBS Group AG					Andrew Johnson	Director

Showing 1 to 1 of 1 entries